Growth Metrics

Evolent Health (EVH) Operating Income (2016 - 2025)

Evolent Health has reported Operating Income over the past 11 years, most recently at -$408.2 million for Q4 2025.

  • Quarterly results put Operating Income at -$408.2 million for Q4 2025, down 2095.26% from a year ago — trailing twelve months through Dec 2025 was -$410.1 million (down 913.06% YoY), and the annual figure for FY2025 was -$410.1 million, down 913.06%.
  • Operating Income for Q4 2025 was -$408.2 million at Evolent Health, down from $886000.0 in the prior quarter.
  • Over the last five years, Operating Income for EVH hit a ceiling of $13.0 million in Q3 2022 and a floor of -$408.2 million in Q4 2025.
  • Median Operating Income over the past 5 years was -$9.0 million (2021), compared with a mean of -$28.0 million.
  • Biggest five-year swings in Operating Income: skyrocketed 296.79% in 2022 and later plummeted 2095.26% in 2025.
  • Evolent Health's Operating Income stood at -$12.2 million in 2021, then soared by 84.62% to -$1.9 million in 2022, then plummeted by 1036.85% to -$21.3 million in 2023, then rose by 12.9% to -$18.6 million in 2024, then plummeted by 2095.26% to -$408.2 million in 2025.
  • The last three reported values for Operating Income were -$408.2 million (Q4 2025), $886000.0 (Q3 2025), and -$1.2 million (Q2 2025) per Business Quant data.